New Modalities for Challenging Targets in Drug Discovery

Area of Science:

• Biochemistry and Molecular Biology
• Drug Discovery and Development
• Therapeutic Modalities

Background:

• Advances in understanding biological systems reveal novel therapeutic targets.
• Protein-protein and protein-nucleic acid interactions are key targets but challenging for traditional small molecules.
• The concept of "new modalities" has gained traction in academic and pharmaceutical research.

Purpose of the Study:

• To define the scope and representative examples of "new modalities" in drug discovery.
• To explore how these new modalities can address challenging biological targets.
• To highlight their application in targeting large binding surfaces and cellular regulation.

Main Methods:

• Literature review and synthesis of current research on novel therapeutic modalities.
• Categorization of "new modalities" including peptidic scaffolds, oligonucleotides, hybrids, and molecular conjugates.
• Analysis of representative examples targeting protein-protein interactions and cellular regulation.

Main Results:

• The term "new modalities" encompasses a range of innovative molecular tools beyond classical small molecules.
• These modalities include novel peptidic scaffolds, oligonucleotides, molecular conjugates, and repurposed small molecules.
• Examples demonstrate efficacy in targeting large surface areas like protein-protein interactions.

Conclusions:

• "New modalities" represent a critical expansion of therapeutic options for complex diseases.
• These approaches are essential for addressing biological targets previously considered undruggable.
• The continued development and application of new modalities will drive future therapeutic innovation.